Melissa I. Chang | 張愛文 MD, FACS, FASCRS (@changtangmd) 's Twitter Profile
Melissa I. Chang | 張愛文 MD, FACS, FASCRS

@changtangmd

👨‍👩‍👧‍👧 | 🌱 | 🧘🏻‍♀️ | colon & rectal surgeon in SE MI | tweets are my own

ID: 2848262884

calendar_today28-10-2014 14:12:17

930 Tweet

798 Followers

539 Following

David Kleiman (@davidkleimanmd) 's Twitter Profile Photo

If you plan to be in Baltimore for ASCRS come join us for a dinner talk on Sunday night to learn about da Vinci 5! You can register to attend by clicking this link: cvent.me/Z08EXa Laila Rashidi Mark Soliman, MD, MBA CRSVirtualEd

If you plan to be in Baltimore for ASCRS come join us for a dinner talk on Sunday night to learn about da Vinci 5!  You can register to attend by clicking this link: cvent.me/Z08EXa <a href="/lailara58/">Laila Rashidi</a> <a href="/MarkSoliman/">Mark Soliman, MD, MBA</a> <a href="/CRSVirtualEd/">CRSVirtualEd</a>
Melissa I. Chang | 張愛文 MD, FACS, FASCRS (@changtangmd) 's Twitter Profile Photo

Excited to join the 15th Annual Career Course faculty in colorectal surgery! Time to discuss the nuts & bolts of practice, share some valuable insights, & help guide the next generation of CRS experts. Welcome to the 💩family. #careercourse ASCRS_1 SAGES is in Tampa in 2026! CRSVirtualEd

Excited to join the 15th Annual Career Course faculty in colorectal surgery! Time to discuss the nuts &amp; bolts of practice, share some valuable insights, &amp; help guide the next generation of CRS experts. Welcome to the 💩family. #careercourse <a href="/ASCRS_1/">ASCRS_1</a> <a href="/SAGES_Updates/">SAGES is in Tampa in 2026!</a> <a href="/CRSVirtualEd/">CRSVirtualEd</a>
Sean Langenfeld (@seanlangenfeld) 's Twitter Profile Photo

Excellent DCRjournal study from Jon Vogel and team looking at 545 US patients with rectal cancer undergoing watch-and-wait after a cCR. Only 18 (3%) were MMR deficient. As much as we all hope to find dMMR rectal cancers to treat with immunotherapy, they're very uncommon.

Excellent <a href="/DCRjournal/">DCRjournal</a> study from <a href="/JonVogel7/">Jon Vogel</a> and team looking at 545 US patients with rectal cancer undergoing watch-and-wait after a cCR.

Only 18 (3%) were MMR deficient.

As much as we all hope to find dMMR rectal cancers to treat with immunotherapy, they're very uncommon.